Investigating how a specific protein affects immune cell function during lung injury from influenza.
The role of epigenetic regulator UHRF1 in stability of induced regulatory T-cell function during influenza A virus-induced lung injury
This study is looking at how a protein called UHRF1 helps keep certain immune cells working well, which is important for healing the lungs after serious infections like the flu, and it aims to find better ways to treat patients with severe lung injuries.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11045008 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the UHRF1 protein in maintaining the function of regulatory T-cells, which are crucial for controlling inflammation and promoting healing in the lungs after injury caused by influenza. The study aims to explore the mechanisms that affect the stability of these immune cells, particularly in the context of severe viral pneumonia and acute respiratory distress syndrome (ARDS). By examining how these cells can be effectively utilized in therapies, the research seeks to improve treatment outcomes for patients suffering from severe lung injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing severe respiratory distress or pneumonia due to viral infections, particularly influenza.
Not a fit: Patients with non-viral causes of respiratory distress or those who do not have significant immune system involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients with severe lung injuries caused by influenza and other viral infections.
How similar studies have performed: Previous research has shown promising results in using regulatory T-cells for therapeutic purposes, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Joudi, Anthony — Northwestern University at Chicago
- Study coordinator: Joudi, Anthony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.